Prof. Dr. Tilman Schirmer

University of Basel
Klingelbergstrasse 50 / 70
CH - 4056 Basel
Biozentrum, Room 311 Phone: +41 61 267 20 89
Curriculum Vitae

Administrative Assistant

Nicole Schwob Sennhauser
Biozentrum, Room 308
Phone: +41 61 267 20 81


FIC proteins send bacteria into hibernation

Bacteria do not cease to amaze us with their survival strategies. Prof....more

Keeping the Spirit in the Bottle: How Fic proteins regulate their potentially lethal enzyme activity

Researchers at the Biozentrum of the University of Basel have been able to...more

Breaking down the second messenger c-di-GMP

In collaboration with the MCSG structure genomics center in Argonne, USA,...more

Research group Tilman Schirmer

How do proteins communicate at the molecular level?

High-resolution structures reveal the mechanisms of signal transduction via bacterial second messengers and reveal how host cells are re-programmed by bacteria.

Active center of a Fic enzyme with bound ATP substrate.

Proteins are a major component of cells and fulfill many different functions. We are using X-ray crystallography to determine their three-dimensional structures at the atomic level to deduce their mechanism of action.

How second messengers activate bacteria

Cyclic di-GMP, a small molecule composed of two nucleotides, acts as a transmitter in the bacterial cell. The concentration of this transmitter in the bacterial cell determines whether bacteria become active in the host cells or whether they protect themselves by hiding in biofilms. Our research concentrates on the enzymes responsible for the synthesis and breakdown of this transmitter. The spatial structures show how the activity of these enzymes is controlled by extrinsic signals, thus regulating the concentration of the transmitter in the cell. Elucidation of the molecular mechanism of this signaling pathway opens new ways for the development of drugs against bacterial pathogens.

How bacterial proteins disrupt signaling pathways in the host cells

Certain bacteria inject proteins into the host cell in order to alter cell function to their advantage. We are working with a newly discovered class of these so-called effector proteins that disable specific host proteins in a targeted manner by attachment of the small molecule AMP. Interestingly, the bacteria protect themselves from the action of these toxic proteins by producing an antitoxin. Structures show how this works and give new ideas how one could inactivate effector proteins within the host cell.